Version May 2024
| General measures |
| Ventilation support to correct hypoxemia and, in part, acidosis |
| Optimize intravascular volume |
| Sodium bicarbonate only for severe metabolic acidosis (arterial pH less than 7.10 to 7.15) |
| Aspirin |
| Intravenous heparin |
| Possible glycoprotein IIb/IIIa inhibitor with NSTEMI |
| Insertion of pulmonary artery catheter |
| Specific measures |
| Pharmacologic support |
| Sympathomimetic inotropes (eg, dopamine) |
| Norepinephrine (for refractory hypotension) |
| Mechanical support |
| IABP, usually combined with percutaneous coronary intervention or coronary artery bypass graft surgery or possible thrombolytic therapy |
| Newer devices |
| Left ventricular or biventricular assist devices |
| Percutaneous cardiopulmonary bypass |
| Reperfusion/revascularization |
| Primary percutaneous coronary intervention |
| Coronary artery bypass graft |
| Thrombolytic therapy for patients not receiving PCI in a timely manner |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟
